Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zentalis Pharmaceuticals (ZNTL) Receivables - Other (2022 - 2023)

Historic Receivables - Other for Zentalis Pharmaceuticals (ZNTL) over the last 2 years, with Q1 2023 value amounting to $7.9 million.

  • Zentalis Pharmaceuticals' Receivables - Other rose 23679.73% to $7.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $7.9 million, marking a year-over-year increase of 23679.73%. This contributed to the annual value of $5.9 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Zentalis Pharmaceuticals reported Receivables - Other of $7.9 million as of Q1 2023, which was up 23679.73% from $5.9 million recorded in Q4 2022.
  • In the past 5 years, Zentalis Pharmaceuticals' Receivables - Other registered a high of $7.9 million during Q1 2023, and its lowest value of $2.3 million during Q1 2022.